Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US

By afschroeder • August 5, 2025

Pei PP, Jones M, Hu R, Chen W, Sax PE, Pandya A, Gandhi M, Eron JJ, Currier JS, Wilkin TJ, Reddy KP, Qoshe L, Hyle EP, Freedberg KA. Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US. Clin Infect Dis. 2025 Aug 4:ciaf428. doi: 10.1093/cid/ciaf428. Epub ahead of print. PMID: 40757869.

Tags: clinical trials, HIV, Implementation, Infectious Diseases, long-acting antiretrovirals, Publications, resistance

The transcription factor Ahr1 governs the recruitment of neutrophils to the brain and clearance of Candida albicans during CNS infection

Wakade RS, Solis NV, Ristow LC, Wellington M, Filler SG, Krysan DJ. The transcription factor Ahr1 governs the recruitment of neutrophils to the brain and[...]

Olorofim in Treatment of Patients With Poorly Controlled Disseminated Coccidioidomycosis : A Single-Group, Open-Label, Phase 2b, Multicenter Study

Donovan FM, Johnson RH, Patterson TF, Hoenigl M, Spec A, Sikka MK, Holland SM, Shoham S, Schaenman JM, Mehta SR, Kuran RA, Galgiani JN, Bresnik[...]

The hantavirus question we are not asking

Hensley LE, Halbrook M, Hoff NA, Merritt S, Olinger GG, Skinner B, von Fricken ME, Kindrachuk J, Rimoin AW. The hantavirus question we are not[...]